News
Abecma delay gives Carvykti a chance to catch up
Bristol-Myers Squibb and partner 2seventy bio are facing a delay in …
19781 items found
News
Oxurion files for bankruptcy as DME drug fails
The end of the line is looming for Oxurion, after a clinical trial of …
Market Access
News
Generics group says VPAG may lead to shortages
Among those celebrating today’s agreement on a voluntary rebate …
News
EVERSANA taps Adobe Firefly in quest to ‘pharmatise’ GenAI
EVERSANA has taken another step forwards in its effort to put …
News
AZ launches digital clinical trials business
AstraZeneca has launched a separate business unit that will take what …
Market Access
Supply chains and the importance of transparency
The pandemic revealed that global supply chains for the pharma …
News
'Landmark' deal reached on UK voluntary rebate scheme
After months of wrangling, an agreement has finally been reached on a …
Sales & Marketing
Empathy: The missing link in HCP-pharma relationships?
Empathy is the ability to emotionally understand what other people …
Patients
“Any day now” is today: Pfizer pioneers individual data sharing for US clinical trial participants
At DPHARM 2023 in Boston, Pfizer announced that it has taken the …
News
Bayer pulls atrial fibrillation study for asundexian
Bayer has decided to discontinue a phase 3 trial of its oral Factor …
Market Access
NICE to consult on inflation-busting fee increases
NICE ran a webinar on 2nd November, setting out – ahead of a formal …
R&D
Partner Content
Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
9th Microbiome Movement Summit Europe
Translating Microbiome R&D into Improved Healthcare Outcomes & Commercial Potential
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
